Aadi Bioscience (AADI US)

Analysis

Health Care • United States

Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers. Aadi Bioscience serves patients in the United States.

Refresh

Company Presentation • 05 Aug 2026 21:00

Corporate presentation

Company Presentation • 07 May 2026 19:00

Corporate presentation

Company Presentation • 07 Aug 2025 19:00

Corporate Presentation

Company Presentation • 14 May 2025 07:26

Q1 2025

Company Presentation • 20 Dec 2024 21:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Corporate presentation

Corporate presentation

Corporate Presentation

Q1 2025

Investor Update